Your search:
17 result(s) in 0.04 s
-
DUKAS_183263420_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Pat Wright, left, watches her partner Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, as she demonstrates her motor skills during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263419_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, walks in a hallway to demonstrate her motor skills during her treatment with neurologist Simon Little, UCSF, right, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263418_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Nurse practitioner Monica Volz, with UCSF’s deep-brain stimulation program, works with neurologist Simon Little, UCSF, during a treatment with Parkinson’s patient Deb Zeyen, both not pictured, former VP in Marketing and Internet Development for CBS Television Network, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263417_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263400_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, walks in a hallway to demonstrate her motor skills during her treatment with neurologist Simon Little, UCSF, right, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263399_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, demonstrates her motor skills during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263394_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, works on her motor skills during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263392_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, left, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, and nurse practitioner Monica Volz, with UCSF’s deep-brain stimulation program, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263390_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263367_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, attends her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_173460373_POL
As America's aging population grows, so does a need for Geriatricians
8/7/2024 - San Francisco, Calif., USA - United States: Max the dog checks in as UCSF Geriatrician Dr. Stacy Han visits Mabel Winding, 99, for a doctor’s visit at her home in San Francisco, Calif. Wednesday, Aug. 7, 2024. San Francisco needs more geriatricians, as the aging population is slated to surpass the number of geriatricians expected to enter the field in the future. (Jessica Christian / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
ONLINE_YES -
DUKAS_173460371_POL
As America's aging population grows, so does a need for Geriatricians
8/7/2024 - San Francisco, Calif., USA - United States: Max the dog checks in as UCSF Geriatrician Dr. Stacy Han visits Mabel Winding, 99, for a doctor’s visit at her home in San Francisco, Calif. Wednesday, Aug. 7, 2024. San Francisco needs more geriatricians, as the aging population is slated to surpass the number of geriatricians expected to enter the field in the future. (Jessica Christian / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
ONLINE_YES -
DUKAS_173460366_POL
As America's aging population grows, so does a need for Geriatricians
8/7/2024 - San Francisco, Calif., USA - United States: UCSF Geriatrician Dr. Stacy Han visits Mabel Winding, 99, for a doctor’s visit at her home in San Francisco, Calif. Wednesday, Aug. 7, 2024. San Francisco needs more geriatricians, as the aging population is slated to surpass the number of geriatricians expected to enter the field in the future. (Jessica Christian / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
ONLINE_YES -
DUKAS_173460365_POL
As America's aging population grows, so does a need for Geriatricians
8/7/2024 - San Francisco, Calif., USA - United States: UCSF Geriatrician Dr. Stacy Han visits Mabel Winding, 99, for a doctor’s visit at her home in San Francisco, Calif. Wednesday, Aug. 7, 2024. San Francisco needs more geriatricians, as the aging population is slated to surpass the number of geriatricians expected to enter the field in the future. (Jessica Christian / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
ONLINE_YES -
DUKAS_173460357_POL
As America's aging population grows, so does a need for Geriatricians
8/7/2024 - San Francisco, Calif., USA - United States: UCSF Geriatrician Dr. Stacy Han visits Mabel Winding, 99, for a doctor’s visit at her home in San Francisco, Calif. Wednesday, Aug. 7, 2024. San Francisco needs more geriatricians, as the aging population is slated to surpass the number of geriatricians expected to enter the field in the future. (Jessica Christian / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
ONLINE_YES -
DUKAS_183263398_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, former VP in Marketing and Internet Development for CBS Television Network, walks in a hallway to demonstrate her motor skills during her treatment with neurologist Simon Little, UCSF, right, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James -
DUKAS_183263368_POL
FDA approves deep-brain stimulation treatment for Parkinsons patients
3/24/2025 - San Francisco, California, USA: Parkinson’s patient Deb Zeyen, left, former VP in Marketing and Internet Development for CBS Television Network, drinks water during her treatment with neurologist Simon Little, UCSF, at the UCSF Weill Institute in San Francisco on Monday, March 24, 2025. The FDA has recently approved a personalized treatment for Parkinson's, adaptive deep-brain stimulation. (Yalonda M. James / San Francisco Chronicle / Polaris) (FOTO:DUKAS/POLARIS)
©San Francisco Chronicle/Yalonda M. James